About LL-37
LL-37 is the only human cathelicidin antimicrobial peptide and is widely used in immunology and innate-immunity research. Supplied as a lyophilized powder for laboratory investigations into innate immune signaling, host-defense pathway markers, and immunomodulatory mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Exploring the Role of Cathelicidin LL-37 and Ceragenins in Wound Healing Processes.
Recent research on LL-37: Exploring the Role of Cathelicidin LL-37 and Ceragenins in Wound Healing Processes.
Read Full Study on PubMedLow-dose lipopolysaccharide pretreatment enhanced the proliferation and antibacterial activity of human adipose-derived mesenchymal stem cells.
Recent research on LL-37: Low-dose lipopolysaccharide pretreatment enhanced the proliferation and antibacterial activity of human adipose-derived mesenchymal stem cells.
Read Full Study on PubMedAdditional Studies
Influence of N- and O-glycosylation on structural properties and biological activity of a C-terminal LL-37 fragment.
Recent research on LL-37: Influence of N- and O-glycosylation on structural properties and biological activity of a C-terminal LL-37 fragment.
Read on PubMedEngineering Smart Bimetallic Ionic-Site MOF Nanozyme Nanocomposites for Microenvironment-Responsive Dynamic Therapy of Periapical Periodontitis.
Recent research on LL-37: Engineering Smart Bimetallic Ionic-Site MOF Nanozyme Nanocomposites for Microenvironment-Responsive Dynamic Therapy of Periapical Periodontitis.
Read on PubMedAnalysis of Antimicrobial Peptide Expression Under Acute and Chronic Alcohol Exposure: A Cross-Sectional Study and a Systematic Review of the Literature.
Recent research on LL-37: Analysis of Antimicrobial Peptide Expression Under Acute and Chronic Alcohol Exposure: A Cross-Sectional Study and a Systematic Review of the Literature.
Read on PubMedStructural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast cancer.
Recent research on LL-37: Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast cancer.
Read on PubMedInvestigation of Regulation and Binding Patterns of the Human Cathelicidin Peptide LL-37 in Complexation with Nucleic Acids, and its Impact on Neutrophil Extracellular Traps.
Recent research on LL-37: Investigation of Regulation and Binding Patterns of the Human Cathelicidin Peptide LL-37 in Complexation with Nucleic Acids, and its Impact on Neutrophil Extracellular Traps.
Read on PubMedMarkov State Models Reveal How hLL-37(17-29) Tetramers Relax from a Disordered State to a Cross-α Amyloid Geometry.
Recent research on LL-37: Markov State Models Reveal How hLL-37(17-29) Tetramers Relax from a Disordered State to a Cross-α Amyloid Geometry.
Read on PubMedRelated Research
Purchase LL-37 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.